BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 559,100 Value ($000) $4,361 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 561,600 Value ($000) $4,263 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 536,000 Value ($000) $4,803 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 522,300 Value ($000) $3,917 Avg Close $8.07 Range $6.96 - $9.50

Q4 2024

Shares 542,100 Value ($000) $4,077 Avg Close $7.59 Range $6.85 - $8.44

Q3 2024

Shares 830 Value ($000) $6 Avg Close $7.60 Range $6.17 - $8.88

Q2 2020

Shares 172,000 Value ($000) $820 Avg Close $3.99 Range $1.80 - $6.29

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	559,100	$4,361	$7.23	$6.00 - $8.17
Q3 2025	561,600	$4,263	$8.33	$7.42 - $9.23
Q2 2025	536,000	$4,803	$9.31	$6.02 - $11.31
Q1 2025	522,300	$3,917	$8.07	$6.96 - $9.50
Q4 2024	542,100	$4,077	$7.59	$6.85 - $8.44
Q3 2024	830	$6	$7.60	$6.17 - $8.88
Q2 2020	172,000	$820	$3.99	$1.80 - $6.29